EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bioorthogonal Photoactivation of 2‐Nitrobenzyl Caged Doxorubicin Anticancer Prodrugs on Gold Nanostars

Juan José Esteve-Moreno, Andrea Escudero, Oscar Ferreira Silvestre, José Manuel Terrés, Mónica Gorbe, Eva Garrido, Carlos Renero-Lecuna, Judith Langer, María Alfonso, Javier Ibañez, Félix Sancenón, Roberto Cao-Milán und 4 weitere

Advanced Materials · 2026

DOI: 10.1002/adma.202510898 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Juan José Esteve-Moreno und 15 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat de València-Universitat Politècnica d…. Hauptthemen laut MEDLINE: Doxorubicin, Gold, Prodrugs, Metal Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Generalitat Valenciana, ERC Advanced Grant Edison, CIBER-Consorcio Centro de Investigación Biomédica en Red.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bioorthogonal chemistry that can be controlled through near‐infrared (NIR) light is a promising route to therapeutics. This study proposes a method to intracellularly photoactivate prodrugs using plasmonic gold nanostars (AuNSt) and NIR irradiation. Two strategies are followed. On one hand, doxorubicin (Dox) masked with a 2‐nitrobenzyl carbamate (proDox 1 ) is used as a photoactivatable prodrug. In the second strategy, a photolabile Dox prodrug (proDox 2 ) obtained by modification of Dox with 2‐nitrobenzyl diol bearing a disulfide is attached to the AuNSt surface. Under NIR irradiation AuNSt induce local electromagnetic field enhancement, leading to photocleavage of the 2‐nitrobenzyl moiety in both proDox 1 and proDox 2 , and subsequent Dox release. Near field enhancement by excitation of surface plasmons in AuNSt is sufficient to record the surface‐enhanced Raman scattering (SERS) spectra of proDox 1 and proDox 2 . The therapeutic potential of this bioorthogonal photoactivation strategy is confirmed in vitro and in vivo using a mouse model of human melanoma. NIR‐activated AuNSt induce in vivo the intracellular release of Dox and subsequent cancer cell death, thus reducing tumor growth at low irradiation power density to avoid undesired photothermal effects. These results demonstrate that AuNSt are suitable platforms for NIR light‐triggered drug delivery in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinGoldProdrugsMetal NanoparticlesAntineoplastic AgentsNitrobenzenesAnimalsHumansCell Line, TumorMiceInfrared RaysPhotochemical Processes

Stichwörter der Autor:innen

bioorthogonal chemistrycancer therapydoxorubicingold nanostarsnear infrared radiationphotocleavable linkersprodrugs photoactivation

Substanzen

DoxorubicinGoldProdrugsAntineoplastic AgentsNitrobenzenes

Autor:innen und Institutionen

  • Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat de València-Universitat Politècnica de València, Camino de Vera s/n, Valencia, 46022, Spain.
  • CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, 28040, Spain.
  • Unidad Mixta UPV-CIPF de Investigación en Mecanismos de Enfermedades y Nanomedicina, Universitat Politècnica de València-Centro de Investigación Príncipe Felipe, C/ d'Eduardo Primo Yúfera 3, Valencia, 46012, Spain.
  • CIC biomaGUNE, Basque Research and Technology Alliance (BRTA) Paseo de Miramón 194, Donostia-San Sebastián, 20014, Spain.
  • School of Pharmacy, University of Otago, Dunedin, 9016, New Zealand.
  • CINBIO - Universidade de Vigo, Vigo, 36310, Spain.

Förderung

  • Generalitat Valenciana
  • ERC Advanced Grant Edison
  • CIBER-Consorcio Centro de Investigación Biomédica en Red
  • MCIN/AEI Spanish Government
  • Provincial Council of Gipuzkoa, Fellows Gipuzkoa Program to O.F.S

Zitieren

APA

Esteve-Moreno, J. J., Escudero, A., Silvestre, O. F., Terrés, J. M., Gorbe, M., Garrido, E., Renero-Lecuna, C., Langer, J., Alfonso, M., Ibañez, J., Sancenón, F., Cao-Milán, R., Liz-Marzán, L. M., García-Fernández, A., Hernández-Montoto, A., & Martínez-Máñez, R. (2026). Bioorthogonal Photoactivation of 2‐Nitrobenzyl Caged Doxorubicin Anticancer Prodrugs on Gold Nanostars. Advanced Materials. https://doi.org/10.1002/adma.202510898

Vancouver

Esteve-Moreno JJ, Escudero A, Silvestre OF, Terrés JM, Gorbe M, Garrido E, et al. Bioorthogonal Photoactivation of 2‐Nitrobenzyl Caged Doxorubicin Anticancer Prodrugs on Gold Nanostars. Advanced Materials. 2026. doi:10.1002/adma.202510898

BibTeX
@article{EsteveMoreno2026,
  author = {Esteve-Moreno, Juan José and Escudero, Andrea and Silvestre, Oscar Ferreira and Terrés, José Manuel and Gorbe, Mónica and Garrido, Eva and Renero-Lecuna, Carlos and Langer, Judith and Alfonso, María and Ibañez, Javier and Sancenón, Félix and Cao-Milán, Roberto and Liz-Marzán, Luis M and García-Fernández, Alba and Hernández-Montoto, Andy and Martínez-Máñez, Ramón},
  title = {Bioorthogonal Photoactivation of 2‐Nitrobenzyl Caged Doxorubicin Anticancer Prodrugs on Gold Nanostars},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.202510898}
}
Kostenlos starten →